![Breakthroughs that change patients’ lives]({"type":"image" , "src" : "/sda/112393/JournalAd-TACD-Pfizer-Leaderboard.jpg"})
References
- Hawkins A, Tulloh R. Treatment of pediatric pulmonary hypertension. Vasc Health Risk Manag 2009; 5: 509–24.
- Heath D, Edwards JE. The pathology of hypertensive pulmo-nary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958; 18: 533–47.
- Han MK, McLaughlin VV, Criner GJ, Martinez FJ. Pul-monary diseases and the heart. Circulation 2007; 116: 2992–3005.
- Cioffi G, de Simone G, Mureddu G, Tarantini L, Stefenelli C. Right atrial size and function in patients with pulmonary hypertension associated with disorders of respiratory sys-tem or hypoxemia. Eur J Echo cardiogr 2007; 8: 322–31.
- Ulucam M, Muderrisoglu H, Sezgin A. Giant left atrial appendage aneurysm: the third ventriclel Int J Cardiovasc Imaging 2005; 21: 225-30.
- Duran NE, Ertiirk E, Gündüz S, Ozkan M. Aneurysm of the right atrial appendage in an elderly patient. Turk Kardiyol Dern Ars 2009; 37: 122–4.
![A worldwide pioneer in biotechnology.]({"type":"image" , "src" : "/sda/112403/JournalAd-Amgen-MPU.png"})
![Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.]({"type":"image" , "src" : "/sda/112392/Skyscraper_BristolMyersSquibb.jpg"})